Specializing in corporate and transactional matters, Einat Meisel advises clients on complex international transactions, mergers and acquisitions, public and private securities offerings, venture capital financings, technology licensing and joint venture transactions, corporate governance issues and general corporate matters. Einat represents both emerging growth and multinational companies in a wide variety of industries including healthcare and medical technologies, pharmaceuticals, internet, storage and data management.
Einat also represents private equity and venture capital funds in their investments in Israel.
Einat joined GKH in 2002 and became a partner in 2007. Previously, she worked at Bingham McCutchen (formerly McCutchen, Doyle, Brown & Emerson, LLP), a leading U.S. law firm where she represented clients in complex financial transactions and a full range of corporate and technology matters. She was a founding member and first Executive Director of the California-Israel Chamber of Commerce, a non-profit organization dedicated to strengthening business and trade relations between California and Israel. Einat also served as in-house counsel for Influence, Inc., a medical device company founded by Israeli entrepreneurs, which was acquired by American Medical Systems.
Born in Israel, Einat moved to the U.S. with her family when she was very young and conducted most of her schooling, including her undergraduate and graduate studies in the U.S. Following law school, Einat moved to San Francisco, California where she developed an interest in working with immigrant entrepreneurs and foreign companies, particularly Israeli-related technology businesses.
Education: Indiana University (B.A., Business Administration, 1989); Chicago Kent College of Law (J.D., 1992).
Admitted: Israel Bar, 2003; California Bar, 1994; Illinois Bar, 1992.
Member: Israel Bar Association, California Bar Association, Illinois Bar Association.
Languages: Hebrew and English.